Trending

#STSSW

Latest posts tagged with #STSSW on Bluesky

Latest Top
Trending

Posts tagged #STSSW

Preview
Sharps Technology Reports Strong Solana Staking Income Sharps Technology (NASDAQ:STSS) reported treasury and operational updates on January 26, 2026 focused on its Solana-based digital asset strategy. The company said its validator partners have generated approximately 7% gross APY since inception, outperforming the Solana network average, and that nearly all of its SOL holdings are currently staked. STSS stated it has no corporate debt and maintains sufficient operating capital. In January the company announced a lock-up agreement with its strategic advisor restricting sales of advisory warrants and confirmed no prior sales or hedging, and launched a jointly supported institutional-grade Solana validator in partnership with Coinbase to which it delegated a portion of its SOL treasury holdings.

#STSS #STSSW Sharps Technology Reports Strong Solana Staking Income

www.stocktitan.net/news/STSS/sharps-technol...

0 0 0 0
Preview
Sharps Technology Strengthens Market Confidence with Advisor Lock-Up Agreement Sharps Technology (NASDAQ: STSS) announced a 90-day lock-up with SOL Markets, under which SOL Markets agreed not to sell or otherwise dispose of advisory warrants or any underlying shares issued for advisory and strategic support, effective January 16, 2026.The agreement accompanies the company's recently approved $100 million share buyback program and is presented as a signal of alignment and confidence in STSS’s execution roadmap, partnerships, Solana treasury, and ongoing product R&D initiatives.

#STSS #STSSW Sharps Technology Strengthens Market Confidence with Advisor Lock-Up Agreement

www.stocktitan.net/news/STSS/sharps-technol...

0 0 0 0
Preview
Sharps Technology Reports Strong Growth in Q3 2025 as it Advances Execution of Treasury Strategy Sharps Technology (NASDAQ:STSS) reported Q3 2025 results and updates on its Solana-based treasury and capital markets initiatives dated November 17, 2025. Key facts: a $411 million PIPE (funded with $267M cash/stablecoins and $144M SOL), > 2.0 million SOL in treasury as of Oct 31, 2025, and ~$17.7 million of combined staking revenue and digital-asset fair-value gains in Q3. Cash and stablecoin liquidity was approximately $25.2 million as of Sept 30, 2025. The company completed exit from legacy syringe manufacturing and settled prior litigation, refocusing on medical device distribution and maximizing its SOL treasury.

#STSS #STSSW Sharps Technology Reports Strong Growth in Q3 2025 as it Advances Execution of Treasury Strategy

www.stocktitan.net/news/STSS/sharps-technol...

0 0 0 0
Preview
Sharps Technology, Inc. Acquires Over 2 Million SOL, the Native Asset of Solana, the Fastest and Most Used Public Blockchain NEW YORK, Sept. 2, 2025/ PRNewswire/-- Sharps Technology, Inc. today announced its first acquisition of Solana tokens as part of its digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of the Solana blockchain. Funded from the Company's recent PIPE equity raise, Sharps Technology now holds over 2 million SOL,...

#STSS #STSSW Sharps Technology, Inc. Acquires Over 2 Million SOL, the Native Asset of Solana, the Fastest and Most Used Public Blockchain

www.stocktitan.net/news/STSS/sharps-technol...

0 0 0 0

Breaking News: ( NASDAQ: #STSSW ) InvestorNewsBreaks - Sharps Technology, Inc. (NASDAQ: STSS, STSSW) Closes $400 Million Private Placement, Launches Solana Treasury Strategy

1 0 0 0
Preview
Sharps Technology, Inc. Closes Over $400 Million Private Placement, Launching Solana Digital Asset Treasury Strategy Sharps Technology (NASDAQ:STSS) has successfully closed a significant private placement offering, raising over $400 million through the sale of common stock and stapled warrants at $6.50 per unit. The company could potentially raise up to $1 billion in total proceeds if all warrants are exercised.The company plans to implement a digital asset treasury strategy focused primarily on SOL, the native digital asset of the Solana blockchain. A non-binding LOI with the Solana Foundation includes a commitment to sell $50 million of SOL at a 15% discount to a 30-day time-weighted average price.The private placement attracted notable investors including ParaFi, Pantera, Monarq, and many other prominent financial institutions and digital asset market leaders. The company will maintain its medical device distribution business while providing regular updates on its SOL holdings and performance metrics.

#STSS #STSSW Sharps Technology, Inc. Closes Over $400 Million Private Placement, Launching Solana Digital Asset Treasury Strategy

www.stocktitan.net/news/STSS/sharps-technol...

0 0 0 0
Preview
$400M Crypto Treasury Play: Sharps Technology Plans Largest-Ever Corporate Solana Position with 7% Yield NASDAQ-listed Sharps Technology secures $400M private placement to build SOL treasury, partnering with ParaFi, Pantera. Deal includes $50M discounted SOL purchase from Solana Foundation.

#STSS #STSSW Sharps Technology, Inc. Announces over $400 Million Private Placement seeking to Establish the Largest Solana Digital Asset Treasury Strategy

www.stocktitan.net/news/STSS/sharps-technol...

0 0 0 0
Preview
Sharps Technology Advances Shipment Under $50 Million SoloGard Supply Agreement and Begins Manufacturing Facility Upgrades Sharps Technology (NASDAQ: STSS) has initiated its second commercial shipment of SoloGard syringes under a previously announced $50 million multi-year supply agreement with a leading U.S. healthcare partner. The company is currently executing a $400,000 purchase order as part of a broader five-year agreement to supply up to 500 million SoloGard syringes. To support increased production demands, Sharps is implementing strategic manufacturing upgrades including next-generation injection molding systems, energy-efficient machinery (10x more efficient), enhanced cleanroom environments, and optimized workflows. The SoloGard syringes are FDA and WHO-approved devices featuring ultra-low waste design, standard luer lock compatibility, and re-use prevention technology.

#STSS #STSSW Sharps Technology Advances Shipment Under $50 Million SoloGard Supply Agreement and Begins Manufacturing Facility Upgrades

www.stocktitan.net/news/STSS/sharps-technol...

0 0 0 0

NEWS: ( NASDAQ: #STSSW ) Sharps Technology Begins Shipments Across Three Customer Orders Under Previously Announced Purchase Agreements

0 0 0 0
Preview
Sharps Technology Begins Shipments Across Three Customer Orders Under Previously Announced Purchase Agreements Sharps Technology (NASDAQ: STSS) has initiated commercial shipments across three customer orders, marking its transition to a revenue-generating company. The company delivered its first commercial order of SoloGard syringes under a $50 million supply agreement with a U.S.-based IV flushing solutions leader, starting with a $400,000 order as part of a five-year contract for up to 500 million syringes. Additionally, Sharps shipped SecureGard smart safety syringes worth $100,000 to a Hungarian vaccine provider and commenced delivery of 200,000 units of 1mL low dead space syringes to a Swiss-based provider of cosmetic, dental, and ophthalmic injectable therapies. The total initial purchase commitments amount to approximately $500,000. All products are manufactured at the company's upgraded Hungary-based facility, which features advanced molding and automation technologies to support high-volume production.

#STSS #STSSW Sharps Technology Begins Shipments Across Three Customer Orders Under Previously Announced Purchase Agreements

www.stocktitan.net/news/STSS/sharps-technol...

0 0 0 0
Preview
Sharps Technology Receives ~$100K Initial Purchase Order from Hungarian Vaccine Provider for SecureGard™ Syringes Sharps Technology (NASDAQ: STSS) has secured a $100,000 purchase order for SecureGard™ syringes from a Hungarian vaccine provider, along with an initial qualification order for DisGard™ single-use Sharps Recovery System. Combined with a recently announced $400,000 SoloGard™ order, the company's Q2 orders total approximately $500,000. The SoloGard order is part of a broader $50 million agreement with a U.S. company. This milestone marks Sharps' transition to a commercial-stage company. The company manufactures SecureGard, SoloGard, and DisGard products at their Hungarian facility, where they maintain inventory to meet current and future demand. SecureGard features include low dead space, manual retraction, latex-free composition, and breakaway plunger, available in 1ml, 3ml, and 5ml capacities.

#STSS #STSSW Sharps Technology Receives ~$100K Initial Purchase Order from Hungarian Vaccine Provider for SecureGard™ Syringes

www.stocktitan.net/news/STSS/sharps-technol...

0 0 0 0
Preview
Sharps Technology Secures $400K Initial Purchase Order from U.S. Leader in IV Flushing Solutions as Part of $50 Million SoloGard Supply Agreement Sharps Technology has received a $400,000 initial purchase order from a leading U.S. IV flushing solutions provider, marking its first commercial revenue under a previously announced $50 million supply agreement. The deal, established in July 2024, involves delivering approximately 500 million customized 10mL SoloGard syringes over five years. The company's Hungarian manufacturing facility is ready to fulfill these first orders, with strategic investments made in advanced production technology through partnerships with Husky Medical Molds and BBS Automation. These collaborations aim to streamline production processes and enhance manufacturing efficiency. CEO Robert Hayes describes this as a transformative moment for the company, signaling the transition from agreement to execution phase. The company expects to scale up production volume in coming quarters, leveraging precision molding and advanced automation to meet the growing demand under this significant contract.

#STSS #STSSW Sharps Technology Secures $400K Initial Purchase Order from U.S. Leader in IV Flushing Solutions as Part of $50 Million SoloGard Supply Agreement

www.stocktitan.net/news/STSS/sharps-technol...

0 0 0 0
Preview
Sharps Technology Plans Massive 1:300 Reverse Split - Key Details About Nasdaq Compliance Strategy Critical corporate action: STSS implements 1-for-300 reverse split effective April 27. Impact on share structure and Nasdaq listing status revealed. Get full details.

#STSS #STSSW Sharps Technology Announces Reverse Stock Split

www.stocktitan.net/news/STSS/sharps-technol...

0 0 0 0
Preview
Can This $50M Medical Device Deal Transform Sharps Technology's Market Position? Sharps lands major 500M syringe contract, advances European healthcare expansion, and strengthens manufacturing capabilities following successful $20M capital raise.

#STSS #STSSW Sharps Technology’s CEO Issues Corporate Update Highlighting Agreements for SecureGard and SoloGard and Revenue Developments from Manufacturing Operations in Hungary

www.stocktitan.net/news/STSS/sharps-technol...

0 0 0 0
Preview
Medical Device Maker Raises $20M: Strategic Move or Dilution Risk? Sharps Technology announces $20M public offering at $1.40 per unit, including common stock and two series of warrants. Aegis Capital leads the offering with 15% over-allotment option.

#STSS #STSSW Sharps Technology, Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering

www.stocktitan.net/news/STSS/sharps-technol...

0 0 0 0
Preview
Sharps Technology Lands Major European Deal, Commits to Massive Production Expansion for Safety Syringes | STSS Stock News Sharps Technology secures landmark sales agreements with major European medical supplier, plans to triple production capacity to meet growing demand for safety syringes.

#STSS #STSSW Sharps Technology Signs Sales Agreements to Support Major European Healthcare Network and Sells Out Its Inventory for SecureGard

#StockMarket #stocks #investing

www.stocktitan.net/news/STSS/sharps-technol...

0 0 0 0

#STSS #STSSW Sharps Regains Nasdaq Listing Compliance

www.stocktitan.net/news/STSS/sharps-regains...

0 0 0 0